ANI. "India is a key partner in terms of production of vaccine and we expect that there'll be a restricted emergency use order for the Sputnik V vaccine...this month or next.
After that we will be able to start our vaccine delivery to India," Kirill Dmitriev, Russian Direct Investment Fund chief said.Russia's experimental coronavirus vaccine Sputnik V is 91.6% effective against in protecting people from COVID-19, according to results published in The Lancet on Tuesday.
The new results are based on data from 20,000 participants in the phase III trial"The data published by The Lancet shows that Sputnik V is one of only three vaccines in the world with the efficacy of over 90 per cent but outperforms them in terms of safety, ease of.